Corbus Pharmaceuticals Holdings, Inc. Share Price
Stocks
CRBP
US21833P3010
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
01:30:00 12/09/2026 am IST
|
5-day change | 1st Jan Change | ||
| 8.120 USD | -1.46% |
|
-26.71% | -0.25% |
| Market Cap | 16Cr 14Cr 13Cr 12Cr 22Cr 1.5TCr 22Cr 152.17Cr 59Cr 763.34Cr 59Cr 58Cr 2.41TCr | P/E 2026 * |
-1.48x | P/E 2027 * | -1.41x |
|---|---|---|---|---|---|
| Enterprise Value | 16Cr 14Cr 13Cr 12Cr 22Cr 1.5TCr 22Cr 152.17Cr 59Cr 763.34Cr 59Cr 58Cr 2.41TCr | EV / Sales 2026 * |
141x | EV / Sales 2027 * | 65.4x |
| Free-Float |
98.76% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| CRBP | Delayed | |
CBOE
| CRBP | Real-time | |
|
Tradegate
| 3371 | Real-time | |
|
Boerse Muenchen
| 3371 | Real-time | |
|
Deutsche Boerse AG
| 3371 | Delayed | |
|
Börse Stuttgart
| 3371 | Delayed |
Last Transcript : Corbus Pharmaceuticals Holdings, Inc.
| 1 day | -1.46% | ||
| 1 week | -26.71% | ||
| Current month | -25.57% | ||
| 1 month | -19.44% | ||
| 3 months | -0.85% | ||
| 6 months | -13.71% | ||
| Current year | -0.25% |
| 1 week | 7.95 |  | 11.07 |
| 1 month | 7.95 | | 11.6 |
| Current year | 7.12 | | 12.88 |
| 1 year | 7.12 | | 20.56 |
| 3 years | 3.03 | | 61.9 |
| 5 years | 2.11 | | 61.9 |
| 10 years | 2.11 | | 323.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
Yuval Cohen
CEO | Chief Executive Officer | 51 | 11/04/2014 |
Sean Moran
DFI | Director of Finance/CFO | 68 | 11/04/2014 |
Leonardo Nicacio
CTO | Chief Tech/Sci/R&D Officer | 48 | 06/07/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Yuval Cohen
BRD | Director/Board Member | 51 | 11/04/2014 |
John Jenkins
BRD | Director/Board Member | 68 | 05/06/2018 |
Rachelle Jacques
CHM | Chairman | 54 | 15/05/2025 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 16/08/26 | Free | Chief Technology Officer | 2,50,009 | 1.3494% | ||
| 11/08/26 | Buy | Executive/Senior Manager | 2,600 | 0.0140% | ||
| 07/08/26 | Sell | Chief Financial Officer | -12,000 | 0.0648% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.46% | -26.71% | -14.53% | +19.41% | 16Cr | |
| -2.11% | -1.68% | +43.40% | +95.58% | 6.69TCr | |
| -0.23% | -4.45% | +32.50% | +77.58% | 6.2TCr | |
| +1.67% | +2.47% | -11.32% | +392.05% | 2.83TCr | |
| +0.34% | -2.39% | +21.83% | +12.94% | 2.46TCr | |
| +0.34% | -6.78% | -0.01% | -14.59% | 2.43TCr | |
| +0.43% | -3.37% | +16.22% | -17.48% | 1.94TCr | |
| -3.03% | -2.29% | +181.72% | +333.47% | 1.68TCr | |
| -0.95% | -5.02% | -8.49% | +526.50% | 1.42TCr | |
| +3.24% | -0.31% | -7.34% | +833.51% | 1.4TCr | |
| Average | -0.03% | -5.32% | +25.40% | +225.90% | 2.71TCr | |
| Weighted average by Cap. | -0.29% | -2.84% | +30.57% | +172.37% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 11.11L 10L 9L 8L 15.41L 11Cr 15.49L 1.08Cr 41.4L 5.4Cr 41.73L 40.81L 17Cr | 24L 20.68L 19.58L 17.75L 33.29L 23Cr 33.46L 2.33Cr 89.42L 12Cr 90.13L 88.16L 37Cr |
| Net income | -12Cr -10Cr -9.49Cr -8.6Cr -16Cr -1.11TCr -16Cr -112.66Cr -43Cr -565.11Cr -44Cr -43Cr -1.79TCr | -14Cr -12Cr -11Cr -9.99Cr -19Cr -1.29TCr -19Cr -130.95Cr -50Cr -656.9Cr -51Cr -50Cr -2.08TCr |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/26/11 | $8.120 | -1.46% | 23,47,297 |
| 10/26/10 | $8.240 | -7.00% | 6,46,758 |
| 09/26/09 | $8.860 | -16.38% | 10,04,127 |
| 08/26/08 | $10.60 | -4.38% | 9,15,463 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CRBP Stock
Select your edition
All financial news and data tailored to specific country editions
